EWTX smart money
Edgewise Therapeutics, INC. (EWTX): 1 insider buy, 13 top funds holding it, 2 ETF changes in the public filings.
Insider buys, 12 months$199k
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2025-11-13 | Fox Jonathan C | Director | $199k | $18.64 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 10 | Paradigm Biocapital Advisors LP | ADD +6% | 8.70% | $438M |
| 14 | First Light Asset Management, LLC | ADD +127% | 5.97% | $101M |
| 22 | Braidwell LP | ADD +4% | 3.62% | $84M |
| 24 | Orbimed Advisors LLC | 11.64% | $630M | |
| 25 | Mpm Bioimpact LLC | 4.93% | $64M | |
| 30 | Deep Track Capital, LP | BUY | 0.78% | $47M |
| 46 | Sofinnova Investments, INC. | ADD +4% | 0.79% | $16M |
| 47 | Casdin Capital, LLC | BUY | 0.47% | $11M |
| 50 | Siren, L.L.C. | TRIM -12% | 2.70% | $114M |
| 51 | Dafna Capital Management LLC | 1.92% | $9M | |
| 71 | Baker Bros. Advisors LP | 0.72% | $150M | |
| 84 | Soleus Capital Management, L.P. | TRIM -27% | 0.48% | $13M |
| 86 | Adar1 Capital Management, LLC | ADD +70% | 0.46% | $10M |
ETF changes
| ETF | Change | Value | Report |
|---|---|---|---|
| Ishares U.S. Pharmaceuticals ETF | TRIM | −$500k | 2026-06-30 |
| State Street(R) Spdr(R) S&p(R) Pharmaceuticals ETF | ADD | +$300k | 2026-06-30 |